Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1135 of 1,261
  1. US 6875587

    Human protease inhibitor and polynucleotides encoding the same

    Lexicon Genetics, Inc. Β· Granted Apr 5, 2005 Β· Expires Mar 31, 2025

    expired
  2. US 6875419

    Paramagnetic metal ion-based macrocyclic magnetization transfer contrast agents and method of use

    The Board of Regents of the University of Texas System Β· Granted Apr 5, 2005 Β· Expires Mar 31, 2025

    expired
  3. US 6875736

    Methods for identifying RNA binding compounds

    PTC THERAPEUTICS, INC. Β· Granted Apr 5, 2005 Β· Expires Mar 31, 2025

    expired
  4. US 6875789

    Pyrazole-derived kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Apr 5, 2005 Β· Expires Mar 31, 2025

    expired
  5. DE 10341317

    Mittel zur transdermalen Applikation

    NEUROBIOTEC GMBH [DE] Β· Granted Mar 31, 2005 Β· Expires Mar 26, 2025

    expired
  6. US 6872701

    Glycopeptide phosphonate derivatives

    Theravance, Inc. Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  7. US 6871477

    Method of manufacturing transdermal patches

    United Pharmaceutical Manufacturing Co. Limited Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  8. US 6872804

    Glycopeptide disulfide and thioester derivatives

    Theravance, Inc. Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  9. US 6872385

    Adjuvant preparation for the induction of specific immunity

    The Board of Regents of the University of Texas System Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  10. US 6872398

    Conjugate vaccine against gram-negative bacterial infections

    The United States of America as represented by the Secretary of the Army Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  11. US 6872387

    Three-dimensional hydrogel/cell system

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  12. US 6872718

    Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents

    Takeda Chemical Industries Ltd. Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  13. US 6872728

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  14. US 6872750

    Modulating angiogenesis

    The Regents of the University of California Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  15. US 6872741

    Sodium channel modulators

    Theravance, Inc. Β· Granted Mar 29, 2005 Β· Expires Mar 24, 2025

    expired
  16. WO 2005026133

    ISOXAZOLES UTILISES COMME INHIBITEURS DE PEPTIDE DEFORMALYSE

    ARPIDA AS [DK] Β· Granted Mar 24, 2005 Β· Expires Mar 19, 2025

    expired
  17. US 6869787

    Ricin vaccine and methods of making and using thereof

    The United States of America as represented by the Secretary of the Army Β· Granted Mar 22, 2005 Β· Expires Mar 17, 2025

    expired
  18. US 6870042

    Mutants of streptococcal toxin A and methods of use

    Regents of the University of Minnesota Β· Granted Mar 22, 2005 Β· Expires Mar 17, 2025

    expired
  19. US 6869984

    Dental composition kit

    KURARAY CO., LTD. Β· Granted Mar 22, 2005 Β· Expires Mar 17, 2025

    expired
  20. US 6869925

    Inhibition of retrovirus infection

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 22, 2005 Β· Expires Mar 17, 2025

    expired
  21. US 6869924

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 22, 2005 Β· Expires Mar 17, 2025

    expired
  22. US 6869968

    2-(3H)-oxazolone derivatives and their use as COX-2 inhibitors

    Allmirall Prodesfarma S.A. Β· Granted Mar 22, 2005 Β· Expires Mar 17, 2025

    expired
  23. US 6869959

    Heterocyclic carboxylic acid derivatives

    Institute of Medicinal Molecular Design, Inc. Β· Granted Mar 22, 2005 Β· Expires Mar 17, 2025

    expired
  24. US 6869568

    Functional assay of high-density lipoprotein

    The Regents of the University of California Β· Granted Mar 22, 2005 Β· Expires Mar 17, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.